The demands on pharmaceutical production are rising. Bausch + Ströbel offers solutions that combine technical precision with process security and will be presenting them at interpack 2026.
The pharmaceutical industry faces growing challenges: increasingly potent active ingredients, rising costs, and stricter regulatory requirements necessitate an adaptation of production processes. Errors in production can be expensive and have serious consequences for patients. Therefore, there is a growing need for partners who can deliver not just machines, but complete, reliable production environments. Bausch + Ströbel positions itself as such a partner. The company emphasises that safety arises not solely from technology, but from a deep understanding of pharmaceutical production processes. Since 1967, Bausch + Ströbel has been developing systems and services for aseptic filling and today offers solutions that combine technical precision with process safety.
At interpack 2026, the company, based in Ilshofen, will showcase a mix of established systems and new developments, including an integrated containment system and a new generation of powder filling. A particular focus will be on the filling and sealing machine with an integrated isolator, which ensures product safety when processing sensitive or highly potent active ingredients. The isolator protects the product, process, operator, patient, and manufacturer alike, thus offering a safe, seamless production solution.
This approach highlights the transition of classic mechanical engineers into partners who understand production processes, minimise risks, and create long-term security. For many manufacturers, this exact approach is crucial.
Bausch + Ströbel at interpack 2026: Hall 16, Stand D15
Source: Bausch + Ströbel
